← All trials
NCT02439398
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2014
- Primary completion
- Dec 31, 2015
- Completion date
- Nov 14, 2016
- First posted
- May 8, 2015
- Last posted
- Nov 14, 2017
- Enrollment
- 55
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- CoretherapixLead sponsor
- Clinica Universidad de NavarraCollaborator
- European CommissionCollaborator
- University of ValenciaCollaborator
- University of ValladolidCollaborator
- OsakidetzaCollaborator
- Hospital General Universitario Gregorio MarañonCollaborator
- University of MalagaCollaborator
- University of ParisCollaborator
- Katholieke Universiteit LeuvenCollaborator
- University of SalamancaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.